Biohaven LTD $BHVN

Recent News (11)

• Biohaven (BHVN) Cashes In On Its Biggest Epilepsy Bet Yahoo Finance · 03 Sep 2026 Biohaven (BHVN) Cashes In On Its Biggest Epilepsy Bet
• Biohaven stock holds Buy rating at TD Cowen after SK deal Investing.com · 26 Aug 2026 Biohaven stock holds Buy rating at TD Cowen after SK deal
• Raymond James cuts Biohaven stock price target on asset monetization Investing.com · 26 Aug 2026 Raymond James cuts Biohaven stock price target on asset monetization
• Biohaven shares climb 7% after signing major SK Biopharmaceuticals licensing deal Yahoo Finance · 26 Aug 2026 Biohaven shares climb 7% after signing major SK Biopharmaceuticals licensing deal
• Biggest stock movers Wednesday: SYRE, INTU, BHVN and more Seeking Alpha · 26 Aug 2026 Biggest stock movers Wednesday: SYRE, INTU, BHVN and more  Seeking Alpha
• Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy PR Newswire · 26 Aug 2026 SK Biopharmaceuticals to provide upfront and milestone payments related to the Kv7 platform up to $795 million, along with tiered royalties to Biohaven ranging from the mid-teens to low twenties on U.…
• SK Biopharmaceuticals signs epilepsy drug licensing deal with Biohaven Investing.com · 26 Aug 2026 SK Biopharmaceuticals signs epilepsy drug licensing deal with Biohaven
• Biohaven, Yale win $4M judgment in trade secret case Investing.com · 25 Aug 2026 Biohaven, Yale win $4M judgment in trade secret case
• Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University PR Newswire · 25 Aug 2026 NEW HAVEN, Conn., Aug. 25, 2026 /PRNewswire/ -- Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE: BHVN) and Yale University ("Yale") today announced that the U.S. District Court f…
• Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline? Yahoo Finance · 14 Aug 2026 Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline?
• Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload PR Newswire · 20 Jul 2026 Biohaven also announces new clinical supply agreement with Regeneron to evaluate BHV-1530 in combination with cemiplimab (Libtayo®) Early clinical activity observed: Phase 1 dose-escalation data show …